Literature DB >> 18515691

Diagnosing depression in Alzheimer disease with the national institute of mental health provisional criteria.

Edmond Teng1, John M Ringman, Leslie K Ross, Ruth A Mulnard, Malcolm B Dick, George Bartzokis, Helen D Davies, Douglas Galasko, Linda Hewett, Dan Mungas, Bruce R Reed, Lon S Schneider, Freddi Segal-Gidan, Kristine Yaffe, Jeffrey L Cummings.   

Abstract

OBJECTIVE: To compare the rates of depression in Alzheimer Disease (AD) determined using National Institute of Mental Health (NIMH) provisional criteria for depression in AD (NIMH-dAD) to those determined using other established depression assessment tools.
DESIGN: Descriptive longitudinal cohort study.
SETTING: The Alzheimer's Disease Research Centers of California. PARTICIPANTS: A cohort of 101 patients meeting NINDS-ADRDA criteria for possible/probable AD, intentionally selected to increase the frequency of depression at baseline. MEASUREMENTS: Depression was diagnosed at baseline and after 3 months using NIMH-dAD criteria and the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) Axis I Disorders. Depressive symptoms also were assessed with the Cornell Scale for Depression in Dementia (CSDD), the Geriatric Depression Scale (GDS), and the Neuropsychiatric Inventory Questionnaire.
RESULTS: The baseline frequency of depression using NIMH-dAD criteria (44%) was higher than that obtained using DSM-IV criteria for major depression (14%; Z = -5.50, df = 101, p <0.001) and major or minor depression (36%; Z = -2.86, df = 101, p = 0.021) or using established cut-offs for the CSDD (30%; Z = -2.86, df = 101, p = 0.004) or GDS (33%; Z = -2.04, df = 101, p = 0.041). The NIMH-dAD criteria correctly identified all patients meeting DSM-IV criteria for major depression, and correlated well with DSM-IV criteria for major or minor depression (kappa = 0.753, p <0.001), exhibiting 94% sensitivity and 85% specificity. The higher rates of depression found with NIMH-dAD criteria derived primarily from its less stringent requirements for the frequency and duration of symptoms. Remission rates at 3 months were similar across instruments.
CONCLUSIONS: The NIMH-dAD criteria identify a greater proportion of AD patients as depressed than several other established tools.

Entities:  

Mesh:

Year:  2008        PMID: 18515691      PMCID: PMC2989660          DOI: 10.1097/JGP.0b013e318165dbae

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  33 in total

1.  A rating scale for depression.

Authors:  M HAMILTON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1960-02       Impact factor: 10.154

2.  Criterion-related validity of the Geriatric Depression Scale in Alzheimer's disease.

Authors:  D W Gilley; R S Wilson
Journal:  J Clin Exp Neuropsychol       Date:  1997-08       Impact factor: 2.475

3.  Screening for depression in elderly primary care patients. A comparison of the Center for Epidemiologic Studies-Depression Scale and the Geriatric Depression Scale.

Authors:  J M Lyness; T K Noel; C Cox; D A King; Y Conwell; E D Caine
Journal:  Arch Intern Med       Date:  1997-02-24

4.  Comparison of the Hamilton Depression Rating Scale and the Geriatric Depression Scale: detection of depression in dementia patients.

Authors:  P A Lichtenberg; B A Marcopulos; D A Steiner; J A Tabscott
Journal:  Psychol Rep       Date:  1992-04

5.  The course of psychopathologic features in mild to moderate Alzheimer disease.

Authors:  D P Devanand; D M Jacobs; M X Tang; C Del Castillo-Castaneda; M Sano; K Marder; K Bell; F W Bylsma; J Brandt; M Albert; Y Stern
Journal:  Arch Gen Psychiatry       Date:  1997-03

6.  Disagreement in the reporting of depressive symptoms between patients with dementia of the Alzheimer type and their collateral sources.

Authors:  W J Burke; W H Roccaforte; S P Wengel; D McArthur-Miller; D G Folks; J F Potter
Journal:  Am J Geriatr Psychiatry       Date:  1998       Impact factor: 4.105

7.  The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia.

Authors:  J L Cummings; M Mega; K Gray; S Rosenberg-Thompson; D A Carusi; J Gornbein
Journal:  Neurology       Date:  1994-12       Impact factor: 9.910

8.  Factors attenuating the validity of the Geriatric Depression Scale in a dementia population.

Authors:  E P Feher; G J Larrabee; T H Crook
Journal:  J Am Geriatr Soc       Date:  1992-09       Impact factor: 5.562

9.  Differences between patient and family assessments of depression in Alzheimer's disease.

Authors:  T B Mackenzie; W N Robiner; D S Knopman
Journal:  Am J Psychiatry       Date:  1989-09       Impact factor: 18.112

10.  Depression in Alzheimer's disease: receiver operating characteristic analysis of the Cornell Scale for Depression in Dementia and the Hamilton Depression Scale.

Authors:  S Vida; P Des Rosiers; L Carrier; S Gauthier
Journal:  J Geriatr Psychiatry Neurol       Date:  1994 Jul-Sep       Impact factor: 2.680

View more
  23 in total

1.  Measuring symptoms of depression: comparing the Cornell Scale for Depression in Dementia and the Patient Health Questionnaire-9-Observation Version.

Authors:  Lorraine J Phillips
Journal:  Res Gerontol Nurs       Date:  2011-12-14       Impact factor: 1.571

2.  Commentary on "Design of comprehensive Alzheimer's disease centers to address unmet national needs".

Authors:  Marwan N Sabbagh
Journal:  Alzheimers Dement       Date:  2010-03       Impact factor: 21.566

Review 3.  Depression in cognitive impairment.

Authors:  Laurel D Pellegrino; Matthew E Peters; Constantine G Lyketsos; Christopher M Marano
Journal:  Curr Psychiatry Rep       Date:  2013-09       Impact factor: 5.285

4.  Cognitive and neuropsychiatric impairments in Alzheimer's disease: current treatment strategies.

Authors:  Anna Borisovskaya; Marcella Pascualy; Soo Borson
Journal:  Curr Psychiatry Rep       Date:  2014-09       Impact factor: 5.285

Review 5.  Neuroinflammation, neurodegeneration, and depression.

Authors:  Laura L Hurley; Yousef Tizabi
Journal:  Neurotox Res       Date:  2012-08-16       Impact factor: 3.911

6.  How do the PHQ-2, the PHQ-9 perform in aging services clients with cognitive impairment?

Authors:  Lisa L Boyle; Thomas M Richardson; Hua He; Yinglin Xia; Xin Tu; Malaz Boustani; Yeates Conwell
Journal:  Int J Geriatr Psychiatry       Date:  2010-12-23       Impact factor: 3.485

Review 7.  Management of Late-Life Depression in the Context of Cognitive Impairment: a Review of the Recent Literature.

Authors:  Kathleen S Bingham; Alastair J Flint; Benoit H Mulsant
Journal:  Curr Psychiatry Rep       Date:  2019-07-05       Impact factor: 5.285

8.  Cognitive Profiles on the Severe Impairment Battery Are Similar in Alzheimer Disease and Down Syndrome With Dementia.

Authors:  Malcolm B Dick; Eric Doran; Michael Phelan; Ira T Lott
Journal:  Alzheimer Dis Assoc Disord       Date:  2016 Jul-Sep       Impact factor: 2.703

9.  Walking stabilizes cognitive functioning in Alzheimer's disease (AD) across one year.

Authors:  J Winchester; M B Dick; D Gillen; B Reed; B Miller; J Tinklenberg; D Mungas; H Chui; D Galasko; L Hewett; C W Cotman
Journal:  Arch Gerontol Geriatr       Date:  2012-09-05       Impact factor: 3.250

10.  Depressive Symptoms in Clinical and Incipient Alzheimer's Disease.

Authors:  Julia J Hsiao; Edmond Teng
Journal:  Neurodegener Dis Manag       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.